Skip to main content

Moderna vaccine shows 94.1% efficacy in trial: Study

Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's Covid-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3n334dk

Comments

Popular posts from this blog

Indian national charged in crash that killed teen, victim’s mother calls for deportation

from World News, Today World News, Latest International News, World Breaking News, Trending News of World - Times of India https://ift.tt/EO2Jjm4